Drug utilization review of ciprofloxacin in the outpatient department of Boru Meda Hospital, South Wollo Zone, Amhara Region, Ethiopia

Tessema Tsehay Biru, Amsalu Degu Defersha, Belayneh Kefale Gelaw, Gobezie Temesgen Tegegne

Abstract


Background: The antimicrobial agents developed during the last 60 years are among the most dramatic examples of the advances of modern medicine. Many infectious diseases once considered incurable and lethal are now amenable to treatment with a few pills. They are among the most frequently prescribed medications to day although microbial resistance due to evolutionary and misuse threatens their continued efficacy. One mechanism to ensure correct prescribing and use is drug use evaluations studies. Objective of current study is to evaluate retrospectively of ciprofloxacin use from outpatient medical records by using pre- set criteria in Boru Meda hospital.

Methods: A cross-sectional study on retrospectively collected data was used to evaluate ciprofloxacin use from outpatient medical history records existing from January 18, 2009 to January 17, 2010. Criteria along with thresholds set by experts for undertaking drug use evaluation for ciprofloxacin was used which is modified based on Ethiopian National Drug Formulary and Ethiopian National Standard Treatment Guideline, which are used in the hospital. Data was collected from January 18 to January 25, 2010 using appropriate data collection format.

Results: Twenty six (65%) patients were in the age group of 15 to 49 years and twenty (50%) were females. Thirty eight (95%) and each of thirty seven (92.5%) cases were consistent with the Ethiopian National Standard Treatment Guideline & drug formulary regarding indication, dose & frequency of ciprofloxacin use in the outpatient department of Boru Meda hospital. 47.5% ciprofloxacin use has problem in duration of treatment . There were potential drug interactions with the drug in 40% of the cases. 10% of ciprofloxacin use was against contraindication.

Conclusions: Due From the retrospective Drug Use Evaluation (DUE) study, it was identified that there was inappropriate ciprofloxacin use in the outpatient department of Boru Meda hospital even though the drug’s use regarding indications was a better performance and dosing practices were almost appropriate as per the criteria used for the study (assuming that there were no dose adjustments). There was a great problem concerning the duration of ciprofloxacin drug therapy. Ciprofloxacin use along with potentially interacting drugs and against contraindications was also another problem indicated in the study.


Keywords


Drug use evaluation, BMH, STG, Ciprofloxacin, Boru Meda

Full Text:

PDF

References


Lester AM. Antibiotic and antimicrobial agents. In: Foyes principles of Medicinal chemistry, Lippincott Williams and Wilkins. 5th ed. Philadelphia, USA: Wolters Kluwer; 2002: 819 and 825.

Henry F. Chambers. General considerations of antimicrobial therapy. In: Laurence B. Burtol, Jones L, Keithl, Parker: Goodman and Gilman’s pharmacologic basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006: 1095 -1119.

Bertram G. Katzung. Basic and clinical pharmacology. 7th ed. USA: McGraw-Hill publishers; 1998: 723 and 767.

Moore T, Bykov A, Savelli T, Zagorski A: Guidelines for implementing drug utilization review programs in hospitals, Management Sciences for Health, Arlington VA / Moscow, Russia, 1997. Available at http://pdf.usaid.gov/pdf_docs/PNACE007.pdf. Accessed Jan 1997.

American society of Hospital pharmacists. ASHP Guidelines on Medication Use Evaluation. Am J Health Syst Pharm. 1996;53:1953-5.

Academy of managed care pharmacy, Concepts in Managed Care pharmacy: drug use evaluation. 1998. Available at: http://depts.washington.edu/exphasmed. Accessed Jan 2009.

DACA: National Drug List of Ethiopia, Drug Administration and control Authority of Ethiopia, Addis Ababa, 2002. Available at: http://apps.who.int/medicinedocs/documents/s16179e/s16179e.pdf. Accessed July 2002.

Richard D. Howland & Mary J. Mycek. Principles of antimicrobial. In: Lippincott’s illustrated Reviews: pharmacology. 3rd ed. Philadelphia; 2006: 382-383.

Von Gunten V, Troillet N, Beney J, Boubaker K, Luthi JC, Taffe P, Reymond JP. Impact of an interdisciplinary strategy on antibiotic use: a prospective controlled in three hospitals. J. Antimicrob. Chemother. 2005;55;362-83.

Raveh D, Muallem Zilcha E, Greenberg A, Wiener- well Y, Schlesinger Y, Yinnon AM. Prospective drug utilization evaluation of three broad spectrum antimicrobials: Cefepime, Piperacillin- tazobactam and meropenem. QJ Med. 2006;99:397-476.

Rehana HS, Nagarani MA, Rehan M. A study on the drug prescribing pattern and use of antimicrobial agents at a tertiary care teaching hospital in Eastern Nepal. Indian J Pharmacol. 1998;30:175-80.

Moddley P. Moodley D, Sturm Aw: ciprofloxacin resistant Neisseria gonorrhoea in South Africa Int J Antimicrobial Agents. 2004;24:192-3.

Richard W Druckenbrod, Todd king, J. Edward Herring: Evaluation of potentially unnecessary ciprofloxacin use in Long-Term care facilities, central North Carolina.

American society of hospital pharmacists: Ciprofloxacin drug utilization review and prospective drug use evaluation. Available at: http:// www.theannals.com/cgi/content /abstract /24/1/82. Accessed Jan 2009.

Hammer man A. Green berg A: Drug use evaluation of ciprofloxacin, impact of educational efforts on appropriateness of use, Journal of Clinical Pharmacy and therapeutics. 1997;22(1):415-20.

Dydek GJ, Souney PF, Matthews SJ: Drug use evaluation of ciprofloxacin in the treatment of urinary tract infections in hospitalized patients. Availabale at: http/www.ncbi.nlm.nih.gov/pubmed/1011671. Accessed Jan 2009.

Abdel Muemin IA. Investigation of drug use in health centers in Khartoum state. Sudan Medical Journal. 1999;37:21-6.

Deriba L, Worku F, Girma T. Drug use evaluation of Co- trimoxazole preventive therapy for people living with HIV/AIDS in Jimma University Specialized Hospital, South West Ethiopia, 2007 Jan.

Abier Hamami. RPH. CPHQ. Determination of sample size for drug use evaluation, 2007. Available at http://www.Pharmacorner.com/default.asp/action=particle and ID+136. Accessed Jan 2009.